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Annular elastolytic giant cell 
granuloma treated with topical 
pimecrolimus
Sir,
Annular elastolytic giant cell granuloma is a rare 
granulomatous skin disease characterized by loss 
of elastic fibers along with elastophagocytosis by 
multinucleated giant cells. It clinically presents as small 
papules which evolve into annular and serpiginous 
plaques that have slightly raised borders. The centre 
of the plaque may show hypopigmentation or atrophic 
changes or both. These are found most commonly 
over the sun‑exposed areas but can be seen over 
sun‑protected areas as well. The other clinical variants 
include a pure papular form with absence of centrifugal 
annular lesions and those with reticular, brown to livid, 
partly atrophic skin lesions.[1,2] The etiopathogenesis of 
this condition is not clear. It is thought that ultraviolet 
radiation, heat or other unknown factors transform the 
antigenicity of the elastic fibers thus inducing a cellular 
immune response.[3] The condition usually follows 
a chronic course, although cases of spontaneous 
remission have been described. The treatment remains 
a challenge and several therapeutic modalities have 
been tried. These include topical, intralesional and 
systemic steroids, clofazimine, cryotherapy, dapsone, 
cyclosporine A, methotrexate, psoralen plus ultraviolet 
A therapy, narrowband ultraviolet B therapy, retinoids, 
fumaric acid esters, antimalarials, topical calcineurin 
inhibitors and tranilast alone or in combination with 
pimecrolimus.[1‑5] We report a case of annular elastolytic 
giant cell granuloma successfully treated with topical 
pimecrolimus.
A 63‑year‑old man with complained of two gradually 
increasing mildly itchy, annular plaques over the right 
parietal and occipital scalp for 4 months. The lesion over 
the parietal scalp appeared first and measured 11 cm in 
diameter while the other appeared a month later and 
was 4 cm wide. On examination, these annular plaques 
had slightly raised, brownish, serpiginous borders and a 
hypopigmented atrophic center [Figure 1a and b]. There 
were no other skin or mucosal lesions. Skin biopsy 
revealed a non‑palisading granulomatous infiltrate in the 
upper dermis with many multinucleated giant cells and 
signs of elastophagocytosis [Figure 2a and b]. Van Gieson 
special staining revealed loss of elastic fibers in the areas 
of granulomatous infiltrate [Figure 2c]. On the basis of 
clinical and histopathological data, a diagnosis of annular 
elastolytic giant cell granuloma was made. The patient 
was treated with pimecrolimus 1% cream twice daily. 
The lesions resolved with residual atrophy after 3 weeks 
after which we stopped therapy [Figure 1c and d]. There 
was no recurrence at follow up two months later.
The treatment of annular elastolytic giant cell granuloma 
is empirical as there is no standard therapy for this 
chronic disorder. Limited areas of involvement are 
treated topically, usually with corticosteroids. However 
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Figure 1: Sharply demarcated annular plaques with slightly raised, 
brownish, serpiginous borders and hypopigmented, atrophic 
center localized over the, (a) occipital and, (b) right parietal areas 
of the scalp at the first visit and, (c and d) after 3 weeks of therapy 
with topical pimecrolimus
dc
ba
Figure 2: (a) Non palisading granulomatous infiltrate composed 
predominantly of multinucleated giant cells located in upper 
reticular dermis (H and E, ×40), (b) magnified view of multinucleated 
giant cells with signs of elastophagocytosis (H and E, ×200), 
(c) loss of elastic fibers in the areas of granulomatous infiltrates 
(Van Gieson staining, ×40)
c
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prolonged treatment with topical steroids is not always 
effective and leads to cutaneous atrophy, a finding often 
already present in this condition.[1] Other topical therapies 
include the calcineurin inhibitors tacrolimus and 
pimecrolimus.[1,3] However, the efficacy of pimecrolimus 
has been demonstrated only in association with oral 
tranilast, an anti‑allergic drug which may directly affect 
the activity of cells of the monocyte macrophage line.[3] 
The mechanism by which calcineurin inhibitors work 
in this condition is not clear. Several hypotheses have 
been proposed which include reduction in the number of 
lesional CD4+ T‑cells, decreased production of cytokines 
such as interleukin‑4, interleukin‑13, macrophage colony 
stimulating factor and γ‑interferon, and inhibition of the 
cellular immune reaction inducing granulomas around 
elastic fibers.[1,3]
Although we cannot exclude a spontaneous regression of 
disease, the significant clinical improvement observed 
in our case shortly after starting topical pimecrolimus 
suggests the efficacy of this drug and indicates its 
possible use as monotherapy. Further studies and 
reports are needed to confirm these assumptions.
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